These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 19210358)

  • 21. Initiation, dose reduction, and duration of inhaled corticosteroid therapy.
    O'Byrne PM
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):511-21, vi. PubMed ID: 16054540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trends and directions in the rationalization of pharmacotherapy of bronchial asthma: probing for alternatives.
    Das BP; Sethi A
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):368-78. PubMed ID: 18603937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The practice guideline 'Asthma in adults' (second revision) from the Dutch College of General Practitioners; a response from the perspective of pulmonology].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2008 May; 152(20):1138-40. PubMed ID: 18549137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic inflammation in asthma: a contest of persistence vs resolution.
    Van Hove CL; Maes T; Joos GF; Tournoy KG
    Allergy; 2008 Sep; 63(9):1095-109. PubMed ID: 18616676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can inhaled corticosteroids influence the natural history of asthma?
    Murray CS
    Curr Opin Allergy Clin Immunol; 2008 Feb; 8(1):77-81. PubMed ID: 18188022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment.
    van Rensen EL; Evertse CE; van Schadewijk WA; van Wijngaarden S; Ayre G; Mauad T; Hiemstra PS; Sterk PJ; Rabe KF
    Allergy; 2009 Jan; 64(1):72-80. PubMed ID: 19076931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild persistent asthma: is any treatment needed?
    Lazarus SC
    J Allergy Clin Immunol; 2006 Oct; 118(4):805-8. PubMed ID: 17030230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies.
    Boulet LP; Gauvreau G; Boulay ME; O'Byrne P; Cockcroft DW;
    Allergy; 2007 Oct; 62(10):1101-10. PubMed ID: 17845579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of FeNO measurement in asthma management: the motion for Yes, it's NO--or, the wrong end of the Stick!
    Bush A; Eber E
    Paediatr Respir Rev; 2008 Jun; 9(2):127-31. PubMed ID: 18513673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of asthma in childhood.
    Covar RA; Cool C; Szefler SJ
    J Allergy Clin Immunol; 2005 Apr; 115(4):700-7. PubMed ID: 15805987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asthma in smokers: challenges and opportunities.
    Thomson NC; Chaudhuri R
    Curr Opin Pulm Med; 2009 Jan; 15(1):39-45. PubMed ID: 19077704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noneosinophilic asthma: a distinct clinical and pathologic phenotype.
    Haldar P; Pavord ID
    J Allergy Clin Immunol; 2007 May; 119(5):1043-52; quiz 1053-4. PubMed ID: 17472810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
    Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming steroid insensitivity in smoking asthmatics.
    Ahmad T; Barnes PJ; Adcock IM
    Curr Opin Investig Drugs; 2008 May; 9(5):470-7. PubMed ID: 18465656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma.
    Kierstein S
    IDrugs; 2006 Jun; 9(6):405-8. PubMed ID: 16752308
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe asthma: an overview.
    Moore WC; Peters SP
    J Allergy Clin Immunol; 2006 Mar; 117(3):487-94; quiz 495. PubMed ID: 16522445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond.
    Calzetta L; Rogliani P; Cazzola M; Matera MG
    Expert Opin Drug Discov; 2014 Jun; 9(6):595-607. PubMed ID: 24749518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of asthma control and its impact on optimal treatment strategy.
    Lundback B; Dahl R
    Allergy; 2007 Jun; 62(6):611-9. PubMed ID: 17508964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin E blockade in the treatment of asthma.
    Kuhn R
    Pharmacotherapy; 2007 Oct; 27(10):1412-24. PubMed ID: 17896896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verdict in the case of therapies versus eosinophils: the jury is still out.
    Bochner BS
    J Allergy Clin Immunol; 2004 Jan; 113(1):3-9; quiz 10. PubMed ID: 14713900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.